For this international women's day, we want to recognise not only the incredible women who are facing breast cancer, but also those who are working towards finding a cure.
Today is the International Day of Women and Girls in Science, so we spoke to some of the women funded by Breast Cancer Now to find out more about them.
The Driver Prize is awarded each year to a Breast Cancer Now researcher who has shown outstanding commitment to their field of research and made vital contributions to Breast Cancer Now’s vision.
Running since 1977, the San Antonio Breast Cancer Symposium has been the place to exchange new information in experimental biology, prevention, diagnosis, and treatment of breast cancer.
We caught up with Dr Weekes in order to find out a bit more about his day-to-day work with Breast Cancer Now.
Here are three stories from researchers supported by Breast Cancer Now, talking about their innovative techniques and how they will help save lives.
A team of scientists have recently published some research on PD-L1: a molecule found on the surface of some breast cancer cells.
What has been your career path so far?
I started my career at the University of Sheffield, which is where I studied for my PhD. I was researching how damage in our DNA may lead to neurodegenerative diseases. Because these diseases are caused by high levels of DNA damage, these patients are also at heightened risk of developing cancer. After being awarded my PhD, I came to work as a post-doctoral researcher at the Breast Cancer Now Research Centre at The Institute of Cancer Research.
Each year the National Cancer Research Institute (NCRI) conference gathers researchers, clinicians, people affected by cancer, and industry representatives to discuss recent advances in research, present new findings, and debate the best ways forward.
We’re excited to bring you the latest developments from this year’s conference on breast cancer and beyond.
How well do we know our immune system?
Immunotherapy was one of the hot topics at this year’s conference. Its promise is huge.